SAINT SIMONS ISLAND, Ga., Nov. 15, 2022 /PRNewswire/ -- Intelivation Technologies, a medical device company with a cutting-edge orthopedic portfolio announced today the launch of the Inlet Foot Plating System™. The 2.3/2.8mm Inlet™...
BETHLEHEM, Pa., Nov. 15, 2022 /PRNewswire/ -- Tyber Medical LLC, the global, leading private-label medical device provider for major orthopedic trauma, extremity, and spine companies, has been awarded a U.S. Food and...
KILKENNY, Ireland, Nov. 15, 2022 /PRNewswire/ -- Spinal Stabilization Technologies (SST) has announced the start of the LOPAIN2 clinical trial of the PerQdisc™ Nucleus Replacement Device (NRD). SST's PerQdisc Nucleus Replacement Device will be...
OKLAHOMA CITY--(BUSINESS WIRE)--Xironetic (chiro-net-ik), an early-stage healthcare technology company, today announced its IntraOpVSP™ augmented reality (AR) visualization software for complex surgeries has received clearance from the U.S. Food and Drug...
DEERFIELD, Ill., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of...
FREMONT, Calif., Nov. 14, 2022 /PRNewswire/ -- THINK Surgical, a technology innovator developing orthopedic surgical robots, today announced the implementation of a new, experienced commercial leadership team. Following a recent successful financing...
Wilmington, DE, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Today, Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced that the company’s ARVIS® Augmented Reality Surgical Guidance System received the Industry Innovation Award...
Growing burden of orthopedic injuries to propel product demand in orthopedic devices market; prevalence of orthopedic disorders especially in aging population underpins massive lucrative avenue for commercialization of productsFirms lean...
DEERFIELD, Ill., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of...
PRINCETON, N.J., Nov. 7, 2022 /PRNewswire/ -- Geistlich Pharma North America Inc. is setting the pace for expanded treatment options with the introduction of vallos™, our first demineralized allograft. With two formulations for treatment...